Flowserve Corporation
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Flowserve Corporation (FLS). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| FPD | $2.67B 71.7% | $2.47B 69.7% · -7.7% | $2.52B 69.7% · +2.0% | $3.06B 70.8% · +21.6% | $3.15B 69.2% · +3.0% | $3.23B 68.3% · +2.4% |
| FCD | $1.05B 28.3% | $1.07B 30.3% · +1.8% | $1.10B 30.3% · +2.3% | $1.26B 29.2% · +14.8% | $1.40B 30.8% · +11.4% | $1.50B 31.7% · +6.8% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| FPD | $271.0M 10.1% | – | – | – | – | – |
| FCD | $125.6M 11.9% | – | – | – | – | – |
Large figure: segment operating income. Below it the margin, that is operating income measured against the revenue of the same segment.
Revenue by product line
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Aftermarket | $1.83B 49.0% | $1.84B 51.9% · +0.5% | $1.91B 52.8% · +3.9% | $2.23B 51.7% · +17.0% | $2.34B 51.3% · +4.7% | $2.51B 53.1% · +7.3% |
| Original Equipment | $1.90B 51.0% | $1.70B 48.1% · -10.3% | $1.71B 47.2% · +0.1% | $2.09B 48.3% · +22.3% | $2.22B 48.7% · +6.3% | $2.22B 46.9% · +0.1% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.